subject: Medicines Company: Premium Company Profile [print this page] Medicines Company: Premium Company Profile
The Medicines Company is a pharmaceutical company that provides drugs for the treatment of diseases in the area of acute care. The company's research is focused on developing new and valuable commercially viable products acquired from other pharmaceutical innovators by using its range of clinical and commercial skills.
Scope of this report
* Contains corporate strategy, value chain presence and SWOT Analysis
* Provides detailed business description, segment analysis, 5-year financial trends, key products and key competitors
* Includes information on suppliers/ partners, shareholding structure and key employees with biographies
Research and analysis highlights
The company markets Angiomax (bivalirudin) for use in patients undergoing coronary angioplasty, a procedure to clear restricted blood flow in arteries around the heart. The company is currently evaluating Angiomax for use in additional patient populations, including, in a Phase III trial, patients presenting with acute coronary syndromes (ACS).
The Medicines Company derives majority of its revenues from the product sales of Angiomax indicated for use as an anticoagulant in combination with aspirin in patients with unstable angina undergoing percutaneous transluminal coronary angioplasty (PTCA).
The company also generated revenues from license, collaboration and other during 2006 that include revenues from reimbursement of fees the company paid, for the services rendered by a research organization. During the period 2002-2006, the company's total revenues increased at a robust CAGR of 54%, from $38 million to $214 million.
Key reasons to read this report
* Access all the important information and analysis on the company in a single report
* Understand company's strengths, weaknesses, opportunities and threats along with business strategy and value chain
* Gain access to company's adjusted five year financial data along with key ratios and market capitalization
To know more and to buy a copy of your report to feel free to visit :
